Agency · 1976–2026 · AAAS data
Department of Health and Human Services
The biggest civilian research budget in government, carried almost entirely by the National Institutes of Health.
The Department of Health and Human Services holds the largest civilian research budget in the federal government, and it is overwhelmingly one agency: the National Institutes of Health (NIH), which funds most of the country's biomedical science. In 2024, NIH accounted for roughly 96 percent of the department's research and development (R&D) money, with the Food and Drug Administration, the Centers for Disease Control and Prevention, and the healthcare-quality agency AHRQ sharing the remainder.
The defining event is the NIH doubling. Between 1998 and 2003, Congress deliberately doubled the NIH budget — from about $13.7 billion to $27.2 billion in current dollars — the steepest sustained climb in this entire dataset. After the doubling ended, the budget actually eroded in real terms for more than a decade, bottoming out in the mid-2010s. COVID-19 emergency funding then drove the 2020 total to the series' real-terms record of about $42 billion in 2017 dollars.
Fiscal year 2025 came in at about $48.8 billion in current dollars. The 2026 figure of roughly $31.1 billion — a proposed cut of more than a third — is the estimate from the White House budget request. Congress rejected the cut where it mattered most: NIH's enacted FY 2026 appropriation came to about $47 billion, roughly level with recent years. The budget-cycle section below has the institute-by-institute detail.
Fig. 1 · Budget history
Congress doubled the National Institutes of Health budget between 1998 and 2003 — the steepest sustained climb anywhere in this series.
The HHS research and development (R&D) budget, every fiscal year on record.
- 1998NIH doubling begins. Congress starts a five-year campaign to double the National Institutes of Health budget.
- 2003Doubling completes. NIH funding reaches twice its 1998 level in current dollars.
- 2013Sequestration. Budget Control Act cuts bite during the long post-doubling erosion.
- 2020COVID-19 emergency funding. Pandemic supplementals drive the series' real-terms record, about $42 billion in 2017 dollars.
The numbers behind this figure
| Fiscal year | Nominal dollars | Constant 2017 dollars | R&D share of GDP |
|---|---|---|---|
| 1976 | 2,602 | 9,054 | 0.15% |
| 1977 | 2,874 | 9,325 | 0.14% |
| 1978 | 3,398 | 10,331 | 0.15% |
| 1979 | 3,530 | 9,930 | 0.14% |
| 1980 | 3,806 | 9,847 | 0.14% |
| 1981 | 4,012 | 9,453 | 0.13% |
| 1982 | 3,939 | 8,678 | 0.12% |
| 1983 | 4,371 | 9,227 | 0.12% |
| 1984 | 4,875 | 9,934 | 0.12% |
| 1985 | 5,502 | 10,850 | 0.13% |
| 1986 | 5,653 | 10,902 | 0.12% |
| 1987 | 6,669 | 12,580 | 0.14% |
| 1988 | 7,218 | 13,189 | 0.14% |
| 1989 | 7,964 | 13,986 | 0.14% |
| 1990 | 8,533 | 14,458 | 0.14% |
| 1991 | 9,566 | 15,649 | 0.16% |
| 1992 | 10,180 | 16,246 | 0.16% |
| 1993 | 10,472 | 16,330 | 0.15% |
| 1994 | 11,324 | 17,280 | 0.16% |
| 1995 | 11,517 | 17,210 | 0.15% |
| 1996 | 12,033 | 17,649 | 0.15% |
| 1997 | 12,912 | 18,608 | 0.15% |
| 1998 | 13,842 | 19,701 | 0.15% |
| 1999 | 15,825 | 22,248 | 0.17% |
| 2000 | 18,182 | 25,041 | 0.18% |
| 2001 | 21,045 | 28,298 | 0.2% |
| 2002 | 24,016 | 31,792 | 0.22% |
| 2003 | 27,696 | 35,973 | 0.25% |
| 2004 | 28,521 | 36,162 | 0.24% |
| 2005 | 29,171 | 35,894 | 0.23% |
| 2006 | 28,976 | 34,532 | 0.21% |
| 2007 | 29,621 | 34,355 | 0.21% |
| 2008 | 29,250 | 33,235 | 0.2% |
| 2009 | 31,058 | 34,932 | 0.21% |
| 2010 | 31,758 | 35,412 | 0.21% |
| 2011 | 31,183 | 34,087 | 0.2% |
| 2012 | 31,375 | 33,686 | 0.19% |
| 2013 | 29,802 | 31,427 | 0.18% |
| 2014 | 30,669 | 31,761 | 0.18% |
| 2015 | 30,177 | 30,932 | 0.17% |
| 2016 | 32,059 | 32,601 | 0.17% |
| 2017 | 33,965 | 33,965 | 0.18% |
| 2018 | 36,848 | 36,047 | 0.18% |
| 2019 | 38,459 | 36,941 | 0.18% |
| 2020 | 44,455 | 42,149 | 0.21% |
| 2021 | 42,225 | 38,703 | 0.18% |
| 2022 | 45,173 | 38,699 | 0.18% |
| 2023 | 48,393 | 39,644 | 0.18% |
| 2024 | 47,975 | 38,279 | 0.17% |
| 2025 | 48,757 | 38,068 | 0.17% |
| 2026est. | 31,067 | 23,762 | 0.1% |
Fig. 2 · Where the money goes
NIH carries about 96 percent of the department's research money; FDA, CDC, and AHRQ share the rest.
The major HHS budget lines tracked by AAAS. These are appropriations accounts: they overlap the budget-history series but are not an exact decomposition of it.
The numbers behind this figure
| Fiscal year | Food and Drug Administration | Agency for Healthcare Quality and Research | Centers for Disease Control | National Institutes of Health |
|---|---|---|---|---|
| 1975 | — | — | — | 7,789 |
| 1976 | — | — | — | 8,010 |
| 1977 | — | — | — | 8,255 |
| 1978 | — | — | — | 8,641 |
| 1979 | — | — | — | 8,973 |
| 1980 | — | — | — | 8,872 |
| 1981 | — | — | — | 8,410 |
| 1982 | — | — | — | 8,024 |
| 1983 | — | — | — | 8,495 |
| 1984 | — | — | — | 9,158 |
| 1985 | — | — | — | 10,155 |
| 1986 | — | — | — | 10,149 |
| 1987 | — | — | — | 11,664 |
| 1988 | — | — | — | 12,181 |
| 1989 | — | — | — | 12,548 |
| 1990 | — | — | — | 12,837 |
| 1991 | — | — | — | 13,540 |
| 1992 | — | — | — | 14,238 |
| 1993 | — | — | — | 16,148 |
| 1994 | — | — | — | 16,719 |
| 1995 | — | — | — | 16,885 |
| 1996 | 1,286 | 95 | — | 17,494 |
| 1997 | 1,280 | 140 | — | 18,361 |
| 1998 | 1,318 | 128 | 3,393 | 19,463 |
| 1999 | 1,379 | 198 | 3,716 | 21,973 |
| 2000 | 1,446 | 227 | 4,602 | 24,570 |
| 2001 | 1,541 | 391 | 5,650 | 27,509 |
| 2002 | 1,884 | 412 | 8,679 | 30,873 |
| 2003 | 1,577 | 415 | 8,223 | 34,445 |
| 2004 | 2,086 | 374 | 8,876 | 34,498 |
| 2005 | 2,146 | 380 | 9,510 | 34,077 |
| 2006 | 2,176 | 370 | 9,744 | 33,125 |
| 2007 | 2,282 | 381 | 10,361 | 33,154 |
| 2008 | 2,553 | 377 | 10,358 | 33,300 |
| 2009 | 2,299 | 415 | 7,103 | 33,559 |
| 2010 | 2,582 | 434 | 7,378 | 33,902 |
| 2011 | 2,694 | 656 | 7,098 | 34,373 |
| 2012 | 2,643 | 427 | 5,975 | 32,543 |
| 2013 | 2,471 | 398 | 5,564 | 30,182 |
| 2014 | 2,625 | 447 | 6,010 | 30,822 |
| 2015 | 2,640 | 450 | 6,176 | 30,823 |
| 2016 | 2,728 | 324 | 7,372 | 32,311 |
| 2017 | 2,730 | 317 | 7,029 | 33,486 |
| 2018 | 2,759 | 321 | 7,973 | 35,838 |
| 2019 | 2,987 | 430 | 6,897 | 36,946 |
| 2020 | 2,975 | 407 | 7,052 | 37,997 |
| 2021 | 2,814 | 289 | 6,014 | 34,931 |
| 2022 | 2,758 | 302 | 7,279 | 36,831 |
| 2023 | 2,866 | 298 | 6,289 | 38,000 |
| 2024 | 2,845 | 288 | 7,200 | 36,195 |
| 2025 | 2,735 | 282 | 7,074 | 35,185 |
| 2026est. | 2,422 | — | 3,305 | 21,352 |
Fig. 3 · Basic, applied, or development
NIH splits its money almost evenly between basic and applied research, with essentially no development.
Research and development at National Institutes of Health from 2000, the first year all three categories are reported, split by character of work: basic research asks how the world works, applied research aims at a specific problem, and development turns knowledge into working systems.
The numbers behind this figure
| Fiscal year | Basic research | Applied research | Development |
|---|---|---|---|
| 2000 | 13,906 | 9,497 | — |
| 2001 | 15,650 | 10,653 | — |
| 2002 | 17,149 | 12,371 | — |
| 2003 | 18,391 | 14,414 | — |
| 2004 | 18,818 | 15,454 | — |
| 2005 | 19,470 | 14,464 | — |
| 2006 | 18,507 | 14,414 | — |
| 2007 | 18,134 | 14,627 | — |
| 2008 | 18,073 | 14,201 | — |
| 2009 | 17,731 | 15,583 | — |
| 2010 | 17,977 | 15,833 | — |
| 2011 | 17,501 | 15,045 | — |
| 2012 | 17,072 | 15,005 | — |
| 2013 | 16,059 | 13,695 | — |
| 2014 | 16,347 | 13,805 | — |
| 2015 | 15,311 | 14,018 | — |
| 2016 | 15,754 | 15,275 | — |
| 2017 | 16,625 | 15,794 | — |
| 2018 | 17,756 | 16,711 | — |
| 2019 | 18,244 | 17,177 | — |
| 2020 | 20,610 | 19,842 | — |
| 2021 | 19,244 | 17,920 | — |
| 2022 | 18,632 | 18,580 | — |
| 2023 | 18,724 | 18,896 | — |
| 2024 | 18,139 | 19,822 | 6 |
| 2025 | 17,505 | 20,225 | 5 |
| 2026est. | 10,829 | 12,725 | 2 |
Appropriations
The current budget cycle: FY 2026 enacted, FY 2027 requested
What Congress enacted for fiscal year 2026 and what the White House has requested for FY 2027, account by account. Budget authority in millions of dollars.
The research and development share of this budget, as estimated by AAAS and excluding non-R&D activities in these accounts, came to $45.2B enacted for FY 2026. The ledgers below compare appropriated totals, which fund whole programs and can include activity beyond R&D.
- Cancer Institute, FY 2026 enacted$7.4BFY 2027 request $7.4B+0%
- Allergy and Infectious Diseases, FY 2026 enacted$6.6BFY 2027 request $4.8B-27.9%
- Aging, FY 2026 enacted$4.5BFY 2027 request $4.2B-6.7%
- Heart, Lung, and Blood, FY 2026 enacted$4BFY 2027 request $3.7B-7.3%
- General Medical Sciences, FY 2026 enacted$3.3BFY 2027 request $3.2B-0.7%
- Neurological Disorders, FY 2026 enacted$2.8BFY 2027 request $2.6B-7.3%
- Office of the Director, FY 2026 enacted$2.5BFY 2027 request $2.3B-7.3%
- Diabetes, Digestive, and Kidney, FY 2026 enacted$2.3BFY 2027 request $2.2B-7.2%
- Mental Health, FY 2026 enacted$2.2BFY 2027 request $2B-6.8%
- Child Health & Human Dev, FY 2026 enacted$1.8BFY 2027 request $1.7B-6.7%
- Drug Abuse, FY 2026 enacted$1.7BFY 2027 request $2.1B+26.1%
- ARPA Health, FY 2026 enacted$1.5BFY 2027 request ——
- ARPA-H, FY 2026 enacted$1.5BFY 2027 request $945M-37%
- Environmental Health Sciences, FY 2026 enacted$991MFY 2027 request $646M-34.8%
- Minority Health / Disparities, FY 2026 enacted$942MFY 2027 request $0M-100%
- Natl Center for Advancing Translational Sci, FY 2026 enacted$942MFY 2027 request $873M-7.3%
- Eye Institute, FY 2026 enacted$897MFY 2027 request $833M-7.1%
- Arthritis / Musculoskeletal, FY 2026 enacted$685MFY 2027 request $638M-7%
- Human Genome, FY 2026 enacted$663MFY 2027 request $620M-6.6%
- Alcohol Abuse and Alcoholism, FY 2026 enacted$595MFY 2027 request $0M-100%
- Deafness and Communication, FY 2026 enacted$534MFY 2027 request $500M-6.5%
- Dental Research, FY 2026 enacted$525MFY 2027 request $490M-6.7%
- National Library of Medicine, FY 2026 enacted$498MFY 2027 request $465M-6.6%
- Biomedical Imaging / Bioengineering, FY 2026 enacted$441MFY 2027 request $408M-7.3%
- Buildings and Facilities, FY 2026 enacted$350MFY 2027 request $350M+0%
- Nursing Research, FY 2026 enacted$198MFY 2027 request $138M-30%
- Complementary and Integrative Health, FY 2026 enacted$170MFY 2027 request $0M-100%
- Fogarty International Center, FY 2026 enacted$95MFY 2027 request $0M-100%
- ARPA-Health, FY 2026 enacted—FY 2027 request $945M—
- Total NIH, FY 2026 enacted$47.2BFY 2027 request $41.2B-12.8%
- Centers for Disease Control and Prevention, FY 2026 enacted$9.3BFY 2027 request $6.3B-31.7%
- Biomedical Advanced R&D Authority, FY 2026 enacted$1.1BFY 2027 request $724M-31%
- Project BioShield, FY 2026 enacted$850MFY 2027 request $724M-14.8%
- Agency for Healthcare Research and Quality, FY 2026 enacted$345MFY 2027 request $240M-30.6%
How much research funding does the Department of Health and Human Services receive?
HHS had about $49 billion in R&D budget authority in fiscal year 2025. For fiscal year 2026, Congress enacted about $45 billion.
What research does HHS fund?
The Department of Health and Human Services holds the largest civilian research budget in the federal government, and it is overwhelmingly one agency: the National Institutes of Health (NIH), which funds most of the country's biomedical science. In 2024, NIH accounted for roughly 96 percent of the department's research and development (R&D) money, with the Food and Drug Administration, the Centers for Disease Control and Prevention, and the healthcare-quality agency AHRQ sharing the remainder.
How has HHS's research budget changed over time?
Congress doubled the National Institutes of Health budget between 1998 and 2003 — the steepest sustained climb anywhere in this series.